University Hospital, Antwerp — CureCurrent

How to interpret these research links

Connected source records

The exact organization name University Hospital, Antwerp appears in 80 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials80

Recruiting shown14

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

Methylated Biomarkers of Smoking as a Selection Tool in Participants for Lung Cancer ScreeningNCT07631624 · lead sponsor · 2025-10-04

NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility StudyNCT07121374 · lead sponsor · 2025-07-22

Identifying Biomarkers for Endothelial Dysfunction in Women With PreeclampsiaNCT07084727 · lead sponsor · 2025-07-01

Exercise Capacity Improvement by Conduction System Pacing in heArt Failure patieNts Without Compelling CRT inDicationNCT06278844 · lead sponsor · 2023-12-12

Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural MesotheliomaNCT05765084 · lead sponsor · 2023-02-24

Eccentric Muscle Training in Cardiac RehabilitationNCT07636343 · lead sponsor · 2023-01-20

A Multicenter Retrospective Analysis of Postoperative Respiratory Complications in Children With Obstructive SleepapneaNCT07305168 · lead sponsor · 2022-05-02

A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple SclerosisNCT07020715 · lead sponsor · 2026-07-01

NOT_YET_RECRUITING

A Clinical Trial Evaluating the Safety and Efficacy of Myelin-peptide Loaded tolDC as Treatment for MSNCT06715605 · lead sponsor · 2025-04-30

Compairing R-ICNB and C-ICNB for Postoperative Pain Management After Minimal-invasive Anatomical Lung ResectionNCT07099469 · lead sponsor · 2025-03-25

ACTIVE_NOT_RECRUITING

Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scanNCT06293833 · lead sponsor · 2024-09-01

Remote MS Care in AntwerpNCT06179758 · lead sponsor · 2024-05-23

ACTIVE_NOT_RECRUITING

Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And NeurodegenerationNCT05893225 · lead sponsor · 2023-11-23

ACTIVE_NOT_RECRUITING

Define Predictors for Posttransplant Diabetes Mellitus StudyNCT06440330 · lead sponsor · 2023-09-01

cArdiopulmonary exerCise Test Assessing Multiple biOmarkers and Hormones iN Type 1 diabetEs Under Different CircumstancesNCT05429359 · lead sponsor · 2022-10-01

Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) in Patients With Idiopathic Peripheral NeuropathyNCT04985734 · lead sponsor · 2021-10-01

Validation of a 13C Glucose Breath Test Compared With the Euglycaemic Clamp TestNCT04623320 · lead sponsor · 2020-10-27

Effect of Hearing Loss and Vestibular Decline on Cognitive Function in Older SubjectsNCT04385225 · lead sponsor · 2019-12-16

A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)NCT05268952 · lead sponsor · 2019-05-27

cArdiopulmonary exerCise Test Assessing Multiple bIOmarkers iN Type 1 DiabetesNCT05097339 · lead sponsor · 2019-05-10

Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes MellitusNCT04664036 · lead sponsor · 2018-09-17

Lipohypertrophy Monitoring StudyNCT04659330 · lead sponsor · 2018-06-01

The Use of Faster Acting Aspart in Type 1 Diabetes PatientsNCT04711382 · lead sponsor · 2018-01-29

Autologous Dendritic Cell Vaccination in MesotheliomaNCT02649829 · lead sponsor · 2017-10-03

A "negative"dendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical TrialNCT02618902 · lead sponsor · 2017-05-30

The Link Between "Time In Range" Versus HbA1c and the Presence of Chronic COmplications in Type 1 Diabetes: a Longitudinal StudyNCT05530369 · lead sponsor · 2014-09-01

Comparison Between Levobupivacaine and Levobupivacaine With Dexmedetomidine in Ultrasound Guided Pectoral Nerve BlockNCT03456661 · lead sponsor · 2014-05-19

Prospective Exploratory Study to Assess the Effects of the AlphaCore® Device in Patients With COPDNCT01720680 · lead sponsor · 2012-10-01

Study to Assess the Effect of the NEXThaler® Device (DPI - Dry Powder Inhaler) on the Central and Peripheral Airway Dimensions in Asthmatic PatientsNCT01650441 · lead sponsor · 2012-04-01

Mindfulness Based Intervention (MBI) on the Quality of Life and Non-Motor Symptoms (NMS) of Persons With PDNCT01607697 · lead sponsor · 2012-03-01

Effects of IPV Assessed With Functional ImagingNCT01671540 · lead sponsor · 2011-09-01

Endothelial Dysfunction in Obese ChildrenNCT01461226 · lead sponsor · 2011-06-01

Relation of Visceral Fat and Associated Cytokines With Early Cardiovascular Complications in Type 1 Diabetes.NCT02689570 · lead sponsor · 2011-06-01

Study in NSCLC: is Timely Analysis of EGFR-mutation Status Feasible in Region Antwerp, Belgium.NCT01260038 · lead sponsor · 2010-11-01

Study to Assess the Effect of Formoterol and Beclomethasone Dipropionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT01204034 · lead sponsor · 2010-09-01

Assess Particle Deposition and Acute Effects of Symbicort® Forte Turbohaler®) in COPD Patients.NCT01329276 · lead sponsor · 2010-06-01

Dendritic Cell Vaccination for Patients with Solid TumorsNCT01291420 · lead sponsor · 2010-05-03

Environmental Chemicals and Their Role in ObesityNCT01778868 · lead sponsor · 2009-08-01

Open, Prospective Pilot Study to Obtain Aerosol Distribution in Asthmatic Patients Using Single Photon Emission Computed Tomography (SPECT) for Comparison With Functional Imaging Using Computer MethodsNCT00966758 · lead sponsor · 2009-07-01

Pilot Study to Assess the Effect of High Dose N-acetylcysteine (NAC) in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT00969904 · lead sponsor · 2009-03-01

Computed Tomography (CT) and Lung Function Data Collection for Computational Fluid Dynamics (CFD) in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT00966459 · lead sponsor · 2008-11-01

Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES)NCT00771563 · lead sponsor · 2008-06-01

Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT00911651 · lead sponsor · 2008-06-01

Monitoring Asthma Treatment Using Exhaled Nitric OxideNCT00562991 · lead sponsor · 2007-10-01

Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC)NCT00497315 · lead sponsor · 2006-02-01

Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung CancerNCT00434668 · lead sponsor · 2005-12-01

Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLCNCT00463515 · lead sponsor · 2003-01-01

Effect of IMT in Patients After Acute Exacerbations of COPDNCT07213128 · collaborator · 2026-01-06

Improvement Through Movement - Balance Control and Somatosensory Function in People With Diabetes Mellitus Type 2NCT07786194 · collaborator · 2025-11-13

Continuous Glucose Monitoring for Women With Gestational DiabetesNCT06310356 · collaborator · 2024-11-18

Effectiveness of an eHealth Self-management Support Program for Persistent Pain After Breast Cancer TreatmentNCT06308029 · collaborator · 2024-05-26

Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational DiabetesNCT05569772 · collaborator · 2023-09-14

Global Research Initiative for Patients Screening on MASHNCT05651724 · collaborator · 2023-06-30

The European NAFLD RegistryNCT04442334 · collaborator · 2015-05-01

The COCCOS Study: a Transition Program for Young Persons With Chronic ConditionsNCT07145671 · collaborator · 2025-03-13

ACTIVE_NOT_RECRUITING

Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections: Translating Epidemiology to Deep-phenotyping.NCT07453420 · collaborator · 2024-08-17

ACTIVE_NOT_RECRUITING

Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment.NCT05507034 · collaborator · 2022-10-04

Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via ImagingNCT05254132 · collaborator · 2022-07-01

Evaluation of Glycemic Control in Adults With Type 1 Diabetes When Switching to Insulin DegludecNCT05434559 · collaborator · 2022-02-20

Gait in Rare DiseasesNCT05161494 · collaborator · 2022-01-25

Drugs studied in this sponsor's trials

12 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University Hospital, Antwerp as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

placebo2

acetylcysteine1

albuterol1

atezolizumab1

citalopram1

glucose1

insulin degludec1

insulin glargine 300 UNT/ML [Toujeo]1

placebo RxCUI 8375 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials acetylcysteine RxCUI 197 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial albuterol RxCUI 435 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial atezolizumab RxCUI 1792776 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial citalopram RxCUI 2556 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial glucose RxCUI 4850 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial insulin degludec RxCUI 1670007 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial insulin glargine 300 UNT/ML [Toujeo] RxCUI 1604541 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial ipratropium bromide RxCUI 203212 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial levobupivacaine RxCUI 259453 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial metformin hydrochloride 850 MG Oral Tablet RxCUI 861010 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial semaglutide Pen Injector RxCUI 1991305 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial

Sponsor roles

lead sponsor47

collaborator33

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.